Search research articles
Contact Us
Filters
Showing results (151-160 of 163) with videos related to
Page
of 17
Sort By:
The Lancet. Gastroenterology & Hepatology
|
July 27, 2019
Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial
Stefan Traussnigg, Jörn M Schattenberg, Münevver Demir, et al.
Journal of Hepatology
|
May 23, 2017
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
Peter Fickert, Gideon M Hirschfield, Gerald Denk, et al.
Endoscopy
|
April 19, 2017
Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline
Lars Aabakken, Tom H Karlsen, Jörg Albert, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
November 13, 2018
Pharmacologic IL-6Rα inhibition in cholangiocarcinoma promotes cancer cell growth and survival
Florian Kleinegger, Eva Hofer, Christina Wodlej, et al.
Journal of Lipid Research
|
March 22, 2019
Metabolic disease and ABHD6 alter the circulating bis(monoacylglycerol)phosphate profile in mice and humans
Gernot F Grabner, Nermeen Fawzy, Maria A Pribasnig, et al.
Science Translational Medicine
|
August 13, 2025
FXR adapts hepatic mitochondrial function to increased substrate oxidation in patients with obesity
Katrin Panzitt, Emilian Jungwirth, Lena E Vosko, et al.
Journal of Hepatology
|
May 1, 2018
Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis
Marion J Pollheimer, Silvia Racedo, Amanda Mikels-Vigdal, et al.
Wiener Klinische Wochenschrift
|
October 25, 2017
Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III)
Thomas Reiberger, Andreas Püspök, Maria Schoder, et al.
Oncotarget
|
December 20, 2017
Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6
Nicole Golob-Schwarzl, Caroline Schweiger, Carina Koller, et al.
Oncotarget
|
February 6, 2023
Correction: Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6
Nicole Golob-Schwarzl, Caroline Schweiger, Carina Koller, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 163) with videos related to
Sort By:
Page
of 17
The Lancet. Gastroenterology & Hepatology
|
July 27, 2019
Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial
Stefan Traussnigg, Jörn M Schattenberg, Münevver Demir, et al.
Journal of Hepatology
|
May 23, 2017
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
Peter Fickert, Gideon M Hirschfield, Gerald Denk, et al.
Endoscopy
|
April 19, 2017
Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline
Lars Aabakken, Tom H Karlsen, Jörg Albert, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
November 13, 2018
Pharmacologic IL-6Rα inhibition in cholangiocarcinoma promotes cancer cell growth and survival
Florian Kleinegger, Eva Hofer, Christina Wodlej, et al.
Journal of Lipid Research
|
March 22, 2019
Metabolic disease and ABHD6 alter the circulating bis(monoacylglycerol)phosphate profile in mice and humans
Gernot F Grabner, Nermeen Fawzy, Maria A Pribasnig, et al.
Science Translational Medicine
|
August 13, 2025
FXR adapts hepatic mitochondrial function to increased substrate oxidation in patients with obesity
Katrin Panzitt, Emilian Jungwirth, Lena E Vosko, et al.
Journal of Hepatology
|
May 1, 2018
Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis
Marion J Pollheimer, Silvia Racedo, Amanda Mikels-Vigdal, et al.
Wiener Klinische Wochenschrift
|
October 25, 2017
Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III)
Thomas Reiberger, Andreas Püspök, Maria Schoder, et al.
Oncotarget
|
December 20, 2017
Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6
Nicole Golob-Schwarzl, Caroline Schweiger, Carina Koller, et al.
Oncotarget
|
February 6, 2023
Correction: Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6
Nicole Golob-Schwarzl, Caroline Schweiger, Carina Koller, et al.
Page
of 17